The technology giant Oracle is preparing for one of the most significant capital raises in its history, aiming to secure between $45 and $50 billion. This massive financial move is squarely targeted at expanding its cloud infrastructure to meet exploding demand for artificial intelligence capabilities. However, this aggressive growth strategy comes with a severe cost, as reports emerge of substantial impending job reductions.
Market Skepticism and Legal Challenges
Investors have reacted with caution to Oracle’s ambitious plans. The company’s shares are currently trading near $164, representing a steep decline of approximately 50% from their September 2025 peak above $328. Signs of financial strain are mounting. The cost of insuring Oracle’s debt against default, known as Credit Default Swaps (CDS), hit a five-year high in December 2025. Furthermore, bondholders filed a lawsuit in January 2026, alleging the company obscured its true financing needs. This skepticism underscores the delicate balance Oracle must strike between its AI growth ambitions and escalating financial risks.
The Dual-Path Financing Strategy
On February 1, 2026, Oracle outlined its intention to fund the colossal investment roughly equally through debt and equity. The detailed plan involves an “at-the-market” equity program for up to $20 billion, complemented by an issuance of convertible preferred stock. For the debt portion, the company is preparing a single offering of senior notes early in the year.
Leading investment banks have been appointed to manage the process: Goldman Sachs is heading the bond issuance, while Citigroup is overseeing the equity transactions. This financial offensive is driven by unprecedented demand from major clients, including OpenAI, NVIDIA, Meta, xAI, TikTok, and AMD, who are all pushing for greater AI cloud capacity. Oracle faces immense pressure to deliver, necessitating this substantial capital build-up.
Should investors sell immediately? Or is it worth buying Oracle?
Cost-Cutting Measures on the Table
Parallel to the fundraising effort, analysts from TD Cowen reported on February 2 that Oracle is considering severe cost-cutting measures. The company may eliminate between 20,000 and 30,000 positions. The objective of this drastic workforce reduction is to generate $8 to $10 billion in additional cash flow. These funds are critical to help finance an estimated $156 billion required for data center expansion.
In a move signaling even tighter financial constraints, Oracle is reportedly debating the sale of Cerner, its healthcare IT division. This is the same unit Oracle acquired in 2022 for $28.3 billion. The mere consideration of divesting this recent, major purchase highlights the narrowing financial runway the corporation is navigating.
The planned capital raise and concurrent austerity measures reveal the extraordinarily high price of competing in the cloud sector with hyperscale rivals. Oracle’s strategy demonstrates a full commitment to capturing the AI opportunity, but the path forward is fraught with significant operational and financial challenges.
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from February 2 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 2.
Oracle: Buy or sell? Read more here...
